PharmaShots | Incisive News in 3 Shots

Subscribe Now

$165M

Sarepta Exercises its Exclusive Option to Acquire Myngonexus Therapeutics for $165M

Sarepta Exercises its Exclusive Option to Acquire Myngonexus Therapeutics for $165M

February 27, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us